Navigation Links
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
Date:4/16/2008

-060 treatment was well-tolerated with no clinically meaningful infusion reactions. The most frequently reported drug-related adverse events were fatigue and pyrexia considered to be mild to moderate in severity.

About Anti-CD30 Antibody Therapy

MDX-060 is a fully human antibody that targets CD30, a marker found on activated lymphocytes that is present on malignant cells of Hodgkin's disease (HD) as well as other CD30-expressing cancers. Medarex is currently conducting an ongoing Phase 2 proof-of-concept trial of MDX-060 in combination with gemcitabine for HD. Medarex is also developing MDX-1401, a second-generation non-fucosylated version of the MDX-060 parental antibody, that is enhanced for greater antibody-dependent cellular cytotoxicity and is being explored in a multi-dose, dose-escalation Phase 1 clinical trial for HD.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014 Each year in the ... medical attention. In the military, burn injury is ... battlefield medical care. More than 800 service members ... wounds heal slowly, remain inflamed and often become ... debilitating and functionally damaging. While developments in supportive ...
(Date:9/29/2014)... start of the military conflicts in Iraq and Afghanistan, ... States with traumatic brain injury caused by exposure to ... explosive devices, or IEDs. Symptoms of traumatic brain injury ... and nausea, to more severe impairments in memory and ... Defense has recognized the critical importance and complexity of ...
(Date:9/29/2014)... Research and Markets  has announced the ... & Services, End-User , Application - Global Forecast to ... The global oligonucleotide synthesis market is expected to reach ... growing at a CAGR of 9.8% from 2014 to ... the basis of products and services, applications, end users, ...
(Date:9/29/2014)... diseases and biodiversity loss requires evolutionary thinking, argues ... Express that was co-authored by Bruce Tabashnik ... and Life Sciences. , For the first time, ... progress in addressing a broad set of challenges ... that consider evolutionary histories and the likelihood of ...
Breaking Biology Technology:Faster Healing with Fewer Scars 2Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3
... Iceland, Jan. 4 deCODE genetics,(Nasdaq: DCGN ) ... of deCODE,CEO Kari Stefansson,s presentation at the JPMorgan 26th ... 11:30 am PST / 7:30 pm GMT on,Thursday, January ... webcast can be accessed through the Investors page on ...
... to study technology to reduce greenhouse gas emissions, ... Midland,Company (NYSE: ADM ), the Midwest Geological ... (ISGS) announce that they are,working together on a ... and storage of carbon dioxide from ADM,s ethanol ...
... development programs, including review of positive results from the Phase ... ... Jan. 4 QuatRx Pharmaceuticals Company,today announced that the company chief ... 26th Annual JP Morgan Healthcare,Conference on Tuesday, January 8th, 2008, at ...
Cached Biology Technology:ADM, MGSC and ISGS Announce Carbon Sequestration Project 2ADM, MGSC and ISGS Announce Carbon Sequestration Project 3QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2
(Date:9/29/2014)... Genome Institute (DOE JGI), a DOE Office of ... projects have been selected for the 2015 Community ... Caribbean waters, and from plant root micro-ecosystems, to ... watersheds, the CSP 2015 projects portfolio highlights diverse ... , "These projects catalyze JGI,s strategic shift ...
(Date:9/29/2014)... The BRAF inhibitor dabrafenib has significant anti-tumour activity ... cell lung cancer whose disease has progressed after ... the ESMO 2014 Congress in Madrid, Spain. ... BRAF have generated considerable interest because these mutations ... tyrosine-kinase inhibiting agents," says lead author Dr David ...
(Date:9/29/2014)... Oktoberfest is here, and that means ... for a cold one, taking that first ... chemicals have reacted to form compounds that ... Reactions explains why beers get skunky, and ... brews from going bad. Learn all about ...
Breaking Biology News(10 mins):2015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3
... along the Mississippi River and other areas are altering ... a researcher from Iowa State University. Fred Janzen, ... studied turtle nesting habits and also accumulated research going ... the turtles to find out when they make nests ...
... snakes may slither in saltwater, but they sip the ... zoologist in a paper appearing this month in the ... Physiological and Biochemical Zoology . Harvey Lillywhite ... roughly 60 species of venomous sea snakes worldwide satisfy ...
... incoming administration will confront an array of threats and ... American president, says Steve Fetter, dean of the University ... won, Fetter asked six experts on his faculty with ... recommending steps to address key challenges. Most ...
Cached Biology News:Turtles alter nesting dates due to temperature change says ISU researcher 2Zoologists: Sea snakes seek out freshwater to slake thirst 2Zoologists: Sea snakes seek out freshwater to slake thirst 3Advice to the new administration: UM foreign and domestic policy guide 2Advice to the new administration: UM foreign and domestic policy guide 3Advice to the new administration: UM foreign and domestic policy guide 4Advice to the new administration: UM foreign and domestic policy guide 5Advice to the new administration: UM foreign and domestic policy guide 6Advice to the new administration: UM foreign and domestic policy guide 7
...
Contains L-glutamine....
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
...
Biology Products: